S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
OTCMKTS:BTCY

Biotricity - BTCY Stock Forecast, Price & News

$0.46
-0.02 (-4.17%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.45
$0.52
50-Day Range
$0.46
$0.88
52-Week Range
$0.40
$2.48
Volume
183,987 shs
Average Volume
68,301 shs
Market Capitalization
$24.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Biotricity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
552.2% Upside
$3.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.38) to ($0.26) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars


BTCY stock logo

About Biotricity (OTCMKTS:BTCY) Stock

Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm's FDA-approved Bioflux MCT technology is comprised of monitoring device and software components, which are made available to the market to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Company Calendar

Last Earnings
2/14/2023
Today
3/26/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
44
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+552.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-29,130,000.00
Net Margins
-220.94%
Pretax Margin
-216.64%

Debt

Sales & Book Value

Annual Sales
$7.70 million
Book Value
($0.04) per share

Miscellaneous

Free Float
41,770,000
Market Cap
$24.15 million
Optionable
Not Optionable
Beta
2.44

Key Executives

  • Waqaas Al-Siddiq
    Chairman, President & Chief Executive Officer
  • John Ayanoglou
    Chief Financial Officer
  • Spencer LaDow
    Vice President-Engineering
  • Amir Ali
    Chief Development Officer













BTCY Stock - Frequently Asked Questions

Should I buy or sell Biotricity stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BTCY shares.
View BTCY analyst ratings
or view top-rated stocks.

What is Biotricity's stock price forecast for 2023?

2 brokerages have issued 12 month price targets for Biotricity's stock. Their BTCY share price forecasts range from $2.00 to $4.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 552.2% from the stock's current price.
View analysts price targets for BTCY
or view top-rated stocks among Wall Street analysts.

How have BTCY shares performed in 2023?

Biotricity's stock was trading at $0.4480 at the beginning of the year. Since then, BTCY stock has increased by 2.7% and is now trading at $0.46.
View the best growth stocks for 2023 here
.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) announced its earnings results on Tuesday, February, 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The company had revenue of $2.46 million for the quarter, compared to the consensus estimate of $2.80 million. Biotricity had a negative trailing twelve-month return on equity of 6,795.29% and a negative net margin of 220.94%.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

What is Biotricity's stock symbol?

Biotricity trades on the OTCMKTS under the ticker symbol "BTCY."

Who are Biotricity's major shareholders?

Biotricity's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biotricity's stock price today?

One share of BTCY stock can currently be purchased for approximately $0.46.

How much money does Biotricity make?

Biotricity (OTCMKTS:BTCY) has a market capitalization of $24.15 million and generates $7.70 million in revenue each year. The company earns $-29,130,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.

How can I contact Biotricity?

The official website for the company is www.biotricity.com. The company can be reached via phone at (650) 832-1626 or via email at investors@biotricity.com.

This page (OTCMKTS:BTCY) was last updated on 3/26/2023 by MarketBeat.com Staff